BRAFmutation is not predictive of long-term outcome in papillary thyroid carcinoma

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAFmutations

(2014) Michaela Angelika Ihle et al.   BMC CANCER

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

(2014) Marcia S Brose et al.   LANCET

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

(2013) Mingzhao Xing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer

(2012) Martha A. Zeiger et al.   ANNALS OF SURGICAL ONCOLOGY

BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer

(2012) Gina M. Howell et al.   ANNALS OF SURGICAL ONCOLOGY

Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma

(2012) Harkanwal Halait et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

TheBRAFV600EMutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

(2012) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

(2012) Ralph P. Tufano et al.   MEDICINE

Papillary Thyroid Carcinomas with Cervical Lymph Node Metastases Can Be Stratified into Clinically Relevant Prognostic Categories Using Oncogenic BRAF, the Number of Nodal Metastases, and Extra-Nodal Extension

(2012) Julio Ricarte-Filho et al.   THYROID

The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

(2011) Tae Hyuk Kim et al.   CANCER

The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines

(2011) Elizabeth M. Kurian et al.   DIAGNOSTIC CYTOPATHOLOGY

BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer

(2011) Su-jin Kim et al.   WORLD JOURNAL OF SURGERY

The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma

(2010) Kuai-Lu Lin et al.   ANNALS OF SURGICAL ONCOLOGY

Thyroid Cancer Epidemiology and Prognostic Variables

(2010) J.A. Sipos et al.   CLINICAL ONCOLOGY

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

(2010) Jill C Rubinstein et al.   Journal of Translational Medicine

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005

(2009) Amy Y. Chen et al.   CANCER

Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005

(2009) L. Enewold et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients

(2009) Yasuhiro ITO et al.   ENDOCRINE JOURNAL

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies

(2009) Maria Chiara Zatelli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation

(2009) Linwah Yip et al.   SURGERY

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma

(2008) Xiaolong Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Molecular pathology of thyroid cancer: diagnostic and clinical implications

(2008) James A. Fagin et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

(2008) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM